CSS LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,900
Closed -$18K 1347
2022
Q1
$18K Buy
+7,900
New +$24.6K ﹤0.01% 1077
2021
Q1
Sell
-8,400
Closed -$57K 1117
2020
Q4
$57K Sell
8,400
-4,294
-34% -$34.5K ﹤0.01% 753
2020
Q3
$142K Sell
12,694
-3,206
-20% -$29.3K 0.01% 619
2020
Q2
$100K Buy
+15,900
New +$60.9K 0.01% 549

Other funds holding SRNE

CSS LLC's SRNE Position: Q2 2022 in Review

CSS LLC sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2022, closing a stake of 7,900 shares — an estimated $18K sold.

CSS LLC first reported a position in SRNE in Q2 2020 and held it in 4 quarters. The position peaked at $142K in Q3 2020. 229 funds tracked by Wall St. Rank hold SRNE as of Q2 2022.

  • CSS LLC reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
  • CSS LLC sold 7,900 Sorrento Therapeutics, Inc. shares in Q2 2022, an estimated $18K.
  • CSS LLC first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 4 quarters.
  • CSS LLC's Sorrento Therapeutics, Inc. position peaked at $142K in Q3 2020.
  • 229 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2022.

Based on CSS LLC's 13F filing for Q2 2022, filed 15 Aug 2022.